Meriolins, a New Class of Cell Death–Inducing Kinase Inhibitors with Enhanced Selectivity for Cyclin-Dependent Kinases-Reference-Cited by-同舟云学术

Meriolins, a New Class of Cell Death–Inducing Kinase Inhibitors with Enhanced Selectivity for Cyclin-Dependent Kinases

Published:2007-09-01 Issue:17 Volume:67 Page:8325-8334
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Bettayeb Karima,Tirado Oscar M.,Marionneau-Lambot Séverine,Ferandin Yoan,Lozach Olivier,Morris Jonathan C.,Mateo-Lozano Silvia,Drueckes Peter,Schächtele Christoph,Kubbutat Michael H.G.,Liger François,Marquet Bernard,Joseph Benoît,Echalier Aude,Endicott Jane A.,Notario Vicente,Meijer Laurent

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcoma;Biochemical Pharmacology;2024-08

2. Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs);Cell Death Discovery;2024-06-11

3. A systematic review on understanding the mechanistic pathways and clinical aspects of natural CDK inhibitors on cancer progression.: Unlocking cellular and biochemical mechanisms;Chemico-Biological Interactions;2024-04

4. Novel meriolin derivatives activate the mitochondrial apoptosis pathway in the presence of antiapoptotic Bcl-2;Cell Death Discovery;2024-03-09

5. Drug discovery and optimization based on the co-crystal structure of natural product with target;European Journal of Medicinal Chemistry;2024-02